Viewing Study NCT02110420


Ignite Creation Date: 2025-12-25 @ 4:12 AM
Ignite Modification Date: 2026-03-03 @ 6:46 PM
Study NCT ID: NCT02110420
Status: COMPLETED
Last Update Posted: 2014-10-15
First Post: 2014-02-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: First-in-human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of CC-90001
Sponsor: Celgene Corporation
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Volunteers View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Safety View
None Pharmacokinetics View
None Healthy Subjects View
None First-in-Human View